{"blog": [], "keywords": [{"value": "Crestor (Drug)", "name": "subject", "rank": "1", "is_major": "N"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "2", "is_major": "Y"}, {"value": "Generic Brands and Products", "name": "subject", "rank": "3", "is_major": "Y"}, {"value": "AstraZeneca PLC", "name": "organizations", "rank": "4", "is_major": "Y"}, {"value": "Food and Drug Administration", "name": "organizations", "rank": "5", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/07/21/business/generic-crestor-wins-approval-dealing-a-blow-to-astrazeneca.html", "document_type": "article", "byline": {"person": [{"lastname": "POLLACK", "firstname": "Andrew", "role": "reported", "organization": "", "rank": 1}], "original": "By ANDREW POLLACK"}, "type_of_material": "News", "multimedia": [{"url": "images/2016/07/21/business/21DRUG-1/21DRUG-1-thumbWide.jpg", "legacy": {"wide": "images/2016/07/21/business/21DRUG-1/21DRUG-1-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/07/21/business/21DRUG-1/21DRUG-1-articleLarge.jpg", "legacy": {"xlarge": "images/2016/07/21/business/21DRUG-1/21DRUG-1-articleLarge.jpg", "xlargeheight": "465", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 465}, {"url": "images/2016/07/21/business/21DRUG-1/21DRUG-1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/07/21/business/21DRUG-1/21DRUG-1-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Business Day", "word_count": "801", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "The F.D.A. allowed eight generics of the cholesterol-lowering pill to go on the market, a move that should considerably decrease its price.", "pub_date": "2016-07-21T00:00:00Z", "news_desk": "Business", "headline": {"print_headline": "F.D.A. Approval Ends Bid to Block Generic Drugs", "main": "Generic Crestor Wins Approval, Dealing a Blow to AstraZeneca"}, "print_page": "4", "snippet": "The F.D.A. allowed eight generics of the cholesterol-lowering pill to go on the market, a move that should considerably decrease its price....", "_id": "578fa83538f0d85ae5114898", "slideshow_credits": null, "abstract": "Food and Drug Admin approves generic versions of cholesterol-lowering pill Crestor, stopping attempt by AstraZeneca to block cheaper competition from reaching drug stores."}